Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid symbols : GLAXF save search
GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19
Published: 2022-01-13 (Crawled : 15:30) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
GSK | News | $40.82 -1.02% 230K
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
XNCR | $18.275 -0.52% 18K
|
Health Technology
|
| O: 0.38%
H: 1.12%
C: -1.31%
VIR | $8.075 -0.68% 41K
|
Health Technology
|
| O: 1.05%
H: 1.98%
C: -6.88%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
covid-19 treatment fda application covid authorization merge emergency use authorization
Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19
Published: 2021-12-17 (Crawled : 13:30) - globenewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 2.36%
H: 0.46%
C: 0.46%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
GSK | News | $40.82 -1.02% 230K
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: 0.0%
XNCR | $18.275 -0.52% 18K
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
VIR | $8.075 -0.68% 41K
|
Health Technology
|
| O: -4.59%
H: 0.0%
C: 0.0%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
covid-19 treatment europe granted covid authorization grant
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
Published: 2021-12-07 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 5.22%
H: 0.0%
C: -1.25%
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 2.13%
H: 0.0%
C: 0.0%
GSK | News | $40.82 -1.02% 230K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
VIR | $8.075 -0.68% 41K
|
Health Technology
|
| O: -6.42%
H: 8.6%
C: 8.45%
SRNE | $0.015 56K
|
Health Technology
|
| O: 6.57%
H: 14.77%
C: 11.21%
RDHL | $0.421 -1.59% 89K
|
Health Technology
|
| O: 0.37%
H: 10.37%
C: 9.63%
covid vaccine
CureVac veröffentlicht in „Nature” präklinische Daten des COVID-19-Kandidaten der zweiten Generation, CV2CoV, die vergleichbaren Antikörperspiegel wie bei lizenziertem mRNA-Impfstoff nachweisen
Published: 2021-11-18 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: -6.25%
H: 3.09%
C: -0.45%
GSK | News | $40.82 -1.02% 230K
|
Health Technology
|
| O: -1.66%
H: 0.24%
C: -0.12%
CVAC | $2.42 -6.92% 240K
|
Health Technology
|
| O: 8.03%
H: 4.75%
C: 2.8%
covid cv2cov
GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 Treatment
Published: 2021-11-17 (Crawled : 12:00) - globenewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 1.43%
H: 2.31%
C: 2.27%
GSK | News | $40.82 -1.02% 230K
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
VIR | $8.075 -0.68% 41K
|
Health Technology
|
| O: 9.97%
H: 4.0%
C: -6.28%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
covid treatment biotech technology iot covid-19
Primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19
Published: 2021-11-12 (Crawled : 13:00) - biospace.com/
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: -0.31%
GSK | News | $40.82 -1.02% 230K
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: 0.0%
VIR | $8.075 -0.68% 41K
|
Health Technology
|
| O: 4.66%
H: 0.0%
C: 0.0%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
covid treatment phase 3 trial
CureVac verlagert Fokus der COVID-19-Impfstoffentwicklung auf mRNA-Technologie der zweiten Generation
Published: 2021-10-12 (Crawled : 12:00) - curevac.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 3.38%
H: 0.0%
C: -5.75%
GSK | News | $40.82 -1.02% 230K
|
Health Technology
|
| O: 2.51%
H: 0.15%
C: -1.43%
CVAC | $2.42 -6.92% 240K
|
Health Technology
|
| O: -13.04%
H: 13.08%
C: 9.7%
covid covid-19
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.78 52.14% 15M
|
SYRA | $1.5 51.23% 1M
|
n/a
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
RILY | $30.325 39.62% 6.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
TROO | $1.41 29.36% 280K
|
Manufacturing
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.21 24.9% 580K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.